Skip to main content
Clinical Trials/NCT03164174
NCT03164174
Active, not recruiting
Not Applicable

Atherosclerosis-Progression in Coronary Arteries Compared to Periphery Vessels

Medical University Innsbruck1 site in 1 country64 target enrollmentMay 17, 2017
ConditionsAtherosclerosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atherosclerosis
Sponsor
Medical University Innsbruck
Enrollment
64
Locations
1
Primary Endpoint
Correlation of the atherosclerotic progression between coronary arteries and peripheral arteries
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

The study is a prospective-observational, explorative single-centre cohort study aimed to examine the atherosclerosis progression in coronary arteries compared to peripheral vessels (carotids, femoral arteries). Atherosclerotic alterations in peripheral vessels (IMT, plaque volume, plaque morphology) will be measured with ultrasound (IMT measurements and 3D quantitative plaque volumetry), whereas atherosclerotic alterations in coronary arteries will be tested with cardiac computertomography (CT) (coronary artery calcium score, calcium volume score, plaque morphology).

A total of 55 patients without prior known established vascular diseases will be tested. Cardiac CT and ultrasonography will be performed initially. After 2 years follow-up CT and ultrasound examination will be performed to assess the changes in atherosclerotic burden. Initially and after two years plasma samples will be collected and tested for traditional and novel cardiovascular risk factors.

The primary endpoint of the planned study will be the correlation of the atherosclerotic progression between coronary arteries and peripheral arteries (carotids, femoral arteries).

Secondary endpoints will include the correlation of atherosclerotic progression with established (hypertension, smoking, diabetes, dyslipidemia) and novel risk factors (hsCRP, P-selectin, cholesteryl ester transfer protein (CETP), intercellular adhesion molecule-1 (ICAM-1), CETP TaqIb polymorphism), with cardiovascular event rate, and the additional predictive value of atherosclerotic progression compared to an established risk score (SCORE Card, FRS). Also plaque morphology will be compared between coronary arteries and peripheral vessels.

Registry
clinicaltrials.gov
Start Date
May 17, 2017
End Date
January 2028
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Medical University Innsbruck
Responsible Party
Principal Investigator
Principal Investigator

Peter Marschang

Ao.Univ.Prof.Dr.

Medical University Innsbruck

Eligibility Criteria

Inclusion Criteria

  • Age 30-85 years, no prior established vascular diseases (CAD, PAD, cerebrovascular disease) no diabetes

Exclusion Criteria

  • Prior myocardial revascularisation therapy (aortocoronary bypass, PCI with stent implantation), coronary artery disease (CAD), peripheral artery disease (PAD), cerebrovascular disease (e.g.stroke), diabetes, pregnancy, lactation period, chronic renal insufficiency IIIB or lower (GFR \<45ml/min), manifest hyperthyreosis

Outcomes

Primary Outcomes

Correlation of the atherosclerotic progression between coronary arteries and peripheral arteries

Time Frame: 2 years

Atherosclerotic progression in peripheral vessels (carotids, femoral arteries) will be tested with 3D-ultrasonography and a quantitative 3-D Plaque volumetry will be performed (total plaque volume).Atherosclerotic progression in coronary arteries will be measured with cardiac CT and coronary plaque burden will be assessed (calcium volume score). The percent change of atherosclerotic progression in peripheral vessels (percent change in total plaque volume, mm3) and coronary arteries (percent change in calcium score, Agatston units) will be compared.

Secondary Outcomes

  • Correlation of atherosclerotic progression with cardiovascular event rate(2 years)
  • Comparison of plaque morphology between coronary arteries and peripheral vessels(2 years)
  • Correlation of atherosclerotic progression with established cardiovascular risk factors(2 years)
  • Correlation of atherosclerotic progression with novel cardiovascular risk factors(2 years)
  • Additional predictive value of atherosclerotic progression compared to an established risk score (SCORE Card, FRS).(2 years)

Study Sites (1)

Loading locations...

Similar Trials